New Research Highlights Brain-Gut-Skin Axis in Chronic Skin Diseases

A growing body of scientific research is reshaping how clinicians understand chronic skin conditions, revealing that diseases such as acne, psoriasis, and atopic dermatitis may not be limited to the skin alone. Instead, they appear to be driven by a complex, interconnected system known as the brain-gut-skin axis (BGSA)—a network linking psychological stress, gut health, immune function, and skin inflammation.

Recent findings appearing in Frontiers in Immunology suggest that this axis plays a central role in the development and progression of inflammatory and disfiguring skin diseases.¹ Traditionally, these conditions have been viewed as localized disorders caused primarily by immune dysfunction in the skin. However, researchers now recognize them as systemic conditions influenced by multiple organ systems working in tandem.

At the core of this model is a bidirectional communication network connecting the central nervous system, gastrointestinal tract, and skin, wrote the researchers, describing how signals travel between these systems through neuroendocrine pathways, immune responses, and microbial metabolites.

The implications for treatment are significant. Rather than focusing solely on topical or localized therapies, emerging strategies aim to target multiple points along the BGSA, wrote the researchers, noting, “Therapeutic strategies targeting the BGSA, including microbiome modulation, psychoneuroimmunological interventions, dietary optimization, and integrative therapies, offer promising avenues for holistic, multi-targeted management.”

Microbiome-based interventions, such as probiotics, dietary modifications, and even fecal microbiota transplantation, have shown early promise in reducing disease severity. In parallel, psychoneuroimmunological approaches have gained traction. For example, stress-reduction techniques, such as mindfulness and cognitive behavioral therapy, may help regulate the neuroendocrine system and reduce inflammation. Researchers are also exploring integrative therapies, such as herbal medicine, though these require further clinical validation.

Despite these advances, experts caution that much of the current evidence remains preliminary. Many studies rely on small sample sizes or preclinical models, and inconsistencies in microbiome research make it difficult to draw definitive conclusions. Larger, standardized clinical trials will be essential to fully understand causal relationships and refine treatment approaches.

The researchers noted the importance of future research focusing on clarifying causal relationships, identifying predictive biomarkers, and designing personalized treatment strategies for the axis.

What current research has shown is that disruptions anywhere along this bidirectional communication connection, such as chronic stress or gut microbiome imbalance, can trigger or worsen skin inflammation. Psychological stress is one of the most well-established drivers of this process.² When the body experiences stress, it activates the hypothalamic–pituitary–adrenal (HPA) axis, leading to the release of hormones like cortisol and neuropeptides. These stress mediators can weaken the gut barrier, alter microbial composition, and promote inflammation in the skin.

At the same time, the gut microbiome plays a critical regulatory role. In a healthy state, gut bacteria produce beneficial compounds such as short-chain fatty acids that help maintain immune balance. But when the microbiome becomes imbalanced, also known as dysbiosis, this protective effect is lost. Harmful substances like lipopolysaccharides can enter the bloodstream, triggering systemic inflammation that may manifest in the skin.

The review also noted how the immune system acts as the key messenger across this axis. Cytokines released in response to stress or microbial imbalance can circulate throughout the body, influencing both brain function and skin health. Inflammatory pathways, particularly those involving IL-17 and TNF-alpha, are shared between gut disorders and skin diseases, further supporting the systemic nature of these conditions.

Clinical evidence reinforces this interconnected model. In acne, for example, stress-related hormonal changes and diet-driven gut dysbiosis combine to increase inflammation and oil production in the skin. Psoriasis is similarly linked to gut microbiome alterations and systemic immune activation, while atopic dermatitis involves both skin and gut barrier dysfunction alongside heightened stress responses.

References

1. Guo Z, Yang J, Zhang R, Yan Y, Wang Q, Xu C. The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies. Front Immunol. 2026;17:1737303. doi:10.3389/fimmu.2026.1737303

2. Liu Y-Z, Wang Y-X, Jiang C-L. Inflammation: the common pathway of stress-related diseases. Front Hum Neurosci. 2017;11:316. doi:10.3389/fnhum.2017.00316